VCNX: Vaccinex, Inc Stock Price

Vaccinex, Inc. is accelerating clinical trials through partnerships with medical centers, creating synergy in antibody research. Contractor capacities are ready for mass molecule synthesis, and laboratories are fully equipped. The asset value tracked on this chart is currently at 1.40. The development of treatments for tumors and neurodegeneration relies on blocking proteins that hinder tissue regeneration in US centers.

Share Price: vaccinex.com (VCNX) for 07/04/2022 - 12/28/2024

Summary analytical data breakdowns for Vaccinex Inc. (VCNX)

- current price and projected stock value:

Stock Quotes Vaccinex, Inc.|VCNX - Price Target Chart

- market capitalization information:

Market Capitalization Vaccinex Inc.|VCNX - Real Price to Acquire Entire Company

- book capitalization information:

Net Assets per Single Share Vaccinex|VCNX - Accounting Capitalization|Market Cap to Net Assets Ratio vaccinex.com|VCNX - Total Business Assets

- issuer credit burden and liquidity indicators:

- company profitability and valuation multiples indicators:

VCNX - Company Net Income|Expected Profit Vaccinex, Inc.|VCNX - Market Cap to Earnings|Forward P/E Multiple Vaccinex|VCNX - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Vaccinex Inc.|VCNX - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Vaccinex|VCNX - Earnings per share for the trailing year|Quarterly EPS earnings growth vaccinex.com|VCNX - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Vaccinex, Inc.

- sales revenue and business income indicators:

VCNX - Company Sales|Company Projected Revenue Vaccinex, Inc.|VCNX - Market Cap to Revenue|Forward Price-to-Revenue Multiple Vaccinex Inc.

Summary company analytics:Vaccinex, Inc.

The specific nature of Vaccinex, Inc. (VCNX), with its minimal staff of specialized scientists and reliance on CRO contractors, makes stock price fluctuations a sensitive indicator of market confidence in clinical results. This metric captures actual transaction amounts, establishing the asset's price history to identify critical support levels, which allows investors to objectively assess capital risks and react promptly to price zone breakouts.

Competitors of Vaccinex, Inc.